» Articles » PMID: 16791143

The Neurobiology of Itch

Overview
Specialty Neurology
Date 2006 Jun 23
PMID 16791143
Citations 328
Authors
Affiliations
Soon will be listed here.
Abstract

The neurobiology of itch, which is formally known as pruritus, and its interaction with pain have been illustrated by the complexity of specific mediators, itch-related neuronal pathways and the central processing of itch. Scratch-induced pain can abolish itch, and analgesic opioids can generate itch, which indicates an antagonistic interaction. However, recent data suggest that there is a broad overlap between pain- and itch-related peripheral mediators and/or receptors, and there are astonishingly similar mechanisms of neuronal sensitization in the PNS and the CNS. The antagonistic interaction between pain and itch is already exploited in pruritus therapy, and current research concentrates on the identification of common targets for future analgesic and antipruritic therapy.

Citing Articles

Effects and safety of acupuncture versus non-penetrating sham acupuncture for senile pruritus: Rationale and design for a randomized controlled trial.

Chen H, Liu S, Gao S, Yi J, Shi H, Fang J Contemp Clin Trials Commun. 2025; 44:101454.

PMID: 40027278 PMC: 11872407. DOI: 10.1016/j.conctc.2025.101454.


Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications.

Vafaeian A, Rajabi F, Rezaei N Heliyon. 2025; 11(3):e42226.

PMID: 40007792 PMC: 11850170. DOI: 10.1016/j.heliyon.2025.e42226.


Promising Strategies for the Management of Burn-Wound-Associated Pruritus.

Tenenhaus M, Rennekampff H Eur Burn J. 2025; 6(1).

PMID: 39982335 PMC: 11843913. DOI: 10.3390/ebj6010002.


Practical Guide for Implementing Cryogenic Electron Microscopy Structure Determination in Dermatology Research.

Lomakin I, Devarkar S, Freniere C, Bunick C J Invest Dermatol. 2024; 145(1):22-31.

PMID: 39601740 PMC: 11748023. DOI: 10.1016/j.jid.2024.10.594.


Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study.

Jin B, Hong T, Yoo B, Kim C, Kim D, Kim Y Clin Transl Sci. 2024; 17(10):e70032.

PMID: 39432406 PMC: 11493102. DOI: 10.1111/cts.70032.